UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
JUNE 2, 2014
Date of Report (Date of earliest event Reported)
MESA LABORATORIES, INC.
(Exact Name of registrant as Specified in its Charter)
Commission File Number: 0-11740
COLORADO |
| 84-0872291 |
12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO |
| 80228 |
Issuer’s telephone number, including area code: (303) 987-8000
Not Applicable.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|_| |
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|_| |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|_| |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|_| |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 2.02 | RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
On June 2, 2014, Mesa Laboratories, Inc. issued a press release relating to its results for the three months and year ended March 31, 2014. A copy of the press release is furnished herewith as Exhibit 99.1.
The information furnished in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.
ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
(d) | Exhibits: |
99.1 Press release dated June 2, 2014.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DATE: June 2, 2014 |
|
|
| Mesa Laboratories, Inc. |
| (Registrant) | ||||
|
|
|
|
|
|
|
| BY: | /s/ John J. Sullivan |
|
|
|
| John J. Sullivan |
|
|
|
| President and Chief Executive Officer |